Table of Content

?Table of Contents
 
Executive Dashboard
Purpose of this Experiential Study
5-Step Process to Transformational Growth
Market Scope and Segmentation
Key Questions this Study will Answer
Market Snapshot
Market Engineering Measurements—Human Microbiome Market
Key Findings 
Major Growth Opportunities
Microbiome Ecosystem—Industry Convergence Map
Strategic Imperatives for Growth

Market Overview
Market Definition
Key Types of Microbiome Therapeutics
Understanding Human Microbiome—Major Initiatives
Understanding Human Microbiome—Major Initiatives (continued)
Drivers and Restraints
Impact Mapping of Drivers and Restraints

Market Dynamics
Key Challenges in the Human Microbiome Market
Areas That Will Highly Impact Microbiome Adoption
Regulatory Scenario Assessment—OTC Segment
Regulatory Scenario Assessment—OTC Segment (continued)
Regulatory Scenario Assessment—Microbiome-based Drugs
Regulatory Scenario Assessment—Microbiome-based Drugs (continued)
Regulatory Scenario Assessment—Microbiome-based Drugs (continued)

Growth Environment—Human Microbiome Market
Market Engineering Measurements—Human Microbiome Market
Forecast Assumptions
Revenue Forecast
Forecast Discussions
Revenue Forecast by Segment
Microbiome-based Drugs—Pipeline Analysis
Microbiome-based Drugs—Pipeline Analysis (continued)
Microbiome-based Drugs—Pipeline Analysis (continued)
Key Microbiome-based Drugs to Watch

Competitive Landscape
Vendor Ecosystem
Key Companies to Watch—Enterome Bioscience
Key Companies to Watch—Chr. Hansen
Key Companies to Watch—Seres Therapeutics
Key Companies to Watch—Viome
Other Companies to Watch—Microbiome Therapeutics
Other Companies to Watch—Microbiome Diagnostics
Analysis of Big Pharma Spend on Human Microbiome Market
Analysis of Big Pharma Spend on Human Microbiome Market (continued)
Key Licensing Deals Analysis
Key Licensing Deals Analysis (continued)
Key Licensing Deals Analysis (continued)
Key Companies by Therapeutic Area of Focus and Stage of Microbiome Therapeutic Candidate

Visioning Scenarios
Human Microbiome Market—Macro to Micro Visioning
Key Future Trends in the Human Microbiome Market

Growth Pipeline
Levers for Growth

Growth Opportunities, Strategies—Implementation and Recommendation: Vision and Strategy
Growth Opportunity 1—Microbiome-based Cancer Immunotherapies
Growth Opportunity 1—Microbiome-based Cancer Immunotherapies (continued)
Growth Opportunity 1—Microbiome-based Cancer Immunotherapies (continued)
Growth Opportunity 1—Microbiome-based Cancer Immunotherapies (continued)
Growth Opportunity 2—Personalized Medicine Through Microbiome Companion Diagnostics
Growth Opportunity 2—Personalized Medicine Through Microbiome Companion Diagnostics (continued)
Growth Opportunity 2—Personalized Medicine Through Microbiome Companion Diagnostics (continued)
Growth Opportunity 2—Personalized Medicine Through Microbiome Companion Diagnostics (continued)
Growth Opportunity 2—Personalized Medicine Through Microbiome Companion Diagnostics (continued)

Growth Opportunities, Strategies—Implementation and Recommendation: Brand and Demand
Growth Opportunity 3—Wellness and Data Monetization Through DTCMT
Growth Opportunity 3—Wellness and Data Monetization Through DTCMT (continued)
Growth Opportunity 4—Microbiome (OTC and Therapeutic) Contract Manufacturing
Growth Opportunity 4—Microbiome (OTC and Therapeutic) Contract Manufacturing (continued)
Growth Opportunity Matrix
Focus Geographies for Human Microbiome Companies
Key Therapeutic Areas to Look Out for in Future
Strategic Imperatives for Human Microbiome Companies

The Last Word
3 Big Predictions
Legal Disclaimer

Appendix
Research Till Date Has Identified Broadly 9 Therapy Areas Which Includes Multiple Chronic Diseases
List of Exhibits
List of Exhibits (continued)